Susan Sonne to Adult
This is a "connection" page, showing publications Susan Sonne has written about Adult.
Connection Strength
0.332
-
Development and pilot testing of a video-assisted informed consent process. Contemp Clin Trials. 2013 Sep; 36(1):25-31.
Score: 0.031
-
The relationship between depression and smoking cessation outcomes in treatment-seeking substance abusers. Am J Addict. 2010 Mar-Apr; 19(2):111-8.
Score: 0.025
-
Gender differences in individuals with comorbid alcohol dependence and post-traumatic stress disorder. Am J Addict. 2003 Oct-Dec; 12(5):412-23.
Score: 0.016
-
Bupropion and Naltrexone in Methamphetamine Use Disorder. N Engl J Med. 2021 01 14; 384(2):140-153.
Score: 0.013
-
Naltrexone for individuals with comorbid bipolar disorder and alcohol dependence. J Clin Psychopharmacol. 2000 Feb; 20(1):114-5.
Score: 0.012
-
Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology (Berl). 2020 Feb; 237(2):479-490.
Score: 0.012
-
Blunts versus joints: Cannabis use characteristics and consequences among treatment-seeking adults. Drug Alcohol Depend. 2019 05 01; 198:105-111.
Score: 0.012
-
Tobacco use during cannabis cessation: Use patterns and impact on abstinence in a National Drug Abuse Treatment Clinical Trials Network study. Drug Alcohol Depend. 2018 11 01; 192:59-66.
Score: 0.011
-
Diagnosis of personality disorders in cocaine-dependent individuals. Am J Addict. 1998; 7(1):1-6.
Score: 0.011
-
Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend. 2018 01 01; 182:1-7.
Score: 0.011
-
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 2017 08 01; 177:249-257.
Score: 0.010
-
Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United States. Drug Alcohol Depend. 2017 07 01; 176:14-20.
Score: 0.010
-
Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
Score: 0.010
-
Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat. 2016 07; 66:16-22.
Score: 0.009
-
Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence. J Subst Abuse Treat. 2015 Oct; 57:70-4.
Score: 0.009
-
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp Clin Trials. 2014 Nov; 39(2):211-23.
Score: 0.008
-
Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994 Jun; 182(6):349-52.
Score: 0.008
-
A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. J Clin Psychiatry. 2014 Apr; 75(4):336-43.
Score: 0.008
-
A tale of two stimulants: mentholated cigarettes may play a role in cocaine, but not methamphetamine, dependence. Drug Alcohol Depend. 2013 Dec 15; 133(3):845-51.
Score: 0.008
-
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend. 2013 Jul 01; 131(1-2):112-8.
Score: 0.008
-
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry. 2011 Dec; 68(12):1238-46.
Score: 0.007
-
Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011 Oct; 21(5):455-63.
Score: 0.007
-
Smoking cessation treatment among patients in community-based substance abuse rehabilitation programs: exploring predictors of outcome as clues toward treatment improvement. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):472-8.
Score: 0.007
-
Improving the transition from residential to outpatient addiction treatment: gender differences in response to supportive telephone calls. Am J Drug Alcohol Abuse. 2008; 34(1):47-59.
Score: 0.005
-
Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008 Jul; 35(1):68-77.
Score: 0.005
-
Symptom improvement in co-occurring PTSD and alcohol dependence. J Nerv Ment Dis. 2006 Sep; 194(9):690-6.
Score: 0.005
-
Genomewide linkage scan for opioid dependence and related traits. Am J Hum Genet. 2006 May; 78(5):759-769.
Score: 0.005
-
Alcohol dependence and posttraumatic stress disorder: differences in clinical presentation and response to cognitive-behavioral therapy by order of onset. J Subst Abuse Treat. 2005 Jul; 29(1):29-37.
Score: 0.004
-
Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005 Mar; 29(3):395-401.
Score: 0.004
-
Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders? Compr Psychiatry. 2004 Jul-Aug; 45(4):304-10.
Score: 0.004
-
A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
Score: 0.004
-
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
Score: 0.004
-
Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89.
Score: 0.004
-
Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
Score: 0.004
-
Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychopharmacol. 2001 Feb; 21(1):116-8.
Score: 0.003
-
Paroxetine for social anxiety and alcohol use in dual-diagnosed patients. Depress Anxiety. 2001; 14(4):255-62.
Score: 0.003
-
Valproate for alcoholics with bipolar disorder. Am J Psychiatry. 1999 Jul; 156(7):1122.
Score: 0.003
-
Posttraumatic stress disorder and cocaine dependence. Order of onset. Am J Addict. 1998; 7(2):128-35.
Score: 0.003
-
Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry. 1995 Nov; 56(11):502-5.
Score: 0.002
-
Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995 Mar; 56(3):118-21.
Score: 0.002
-
Fluoxetine-associated side effects and suicidality. J Clin Psychopharmacol. 1993 Aug; 13(4):292-5.
Score: 0.002